- Home
- HBB vs VNDA Comparison
HBB vs VNDA Comparison
Compare HBB & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBB
- VNDA
- Stock Information
- Founded
- HBB 1904
- VNDA 2002
- Country
- HBB United States
- VNDA United States
- Employees
- HBB N/A
- VNDA N/A
- Industry
- HBB Home Furnishings
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- HBB Consumer Discretionary
- VNDA Health Care
- Exchange
- HBB Nasdaq
- VNDA Nasdaq
- Market Cap
- HBB 242.8M
- VNDA 249.4M
- IPO Year
- HBB 2017
- VNDA 2006
- Fundamental
- Price
- HBB $14.53
- VNDA $4.51
- Analyst Decision
- HBB
- VNDA Strong Buy
- Analyst Count
- HBB 0
- VNDA 2
- Target Price
- HBB N/A
- VNDA $16.50
- AVG Volume (30 Days)
- HBB 33.9K
- VNDA 404.6K
- Earning Date
- HBB 10-29-2025
- VNDA 11-05-2025
- Dividend Yield
- HBB 3.28%
- VNDA N/A
- EPS Growth
- HBB N/A
- VNDA N/A
- EPS
- HBB 2.35
- VNDA N/A
- Revenue
- HBB $631,318,000.00
- VNDA $203,467,000.00
- Revenue This Year
- HBB N/A
- VNDA $15.45
- Revenue Next Year
- HBB N/A
- VNDA $37.82
- P/E Ratio
- HBB $6.23
- VNDA N/A
- Revenue Growth
- HBB N/A
- VNDA 11.78
- 52 Week Low
- HBB $12.72
- VNDA $3.81
- 52 Week High
- HBB $31.78
- VNDA $5.55
- Technical
- Relative Strength Index (RSI)
- HBB 47.34
- VNDA 46.90
- Support Level
- HBB $14.31
- VNDA $4.54
- Resistance Level
- HBB $14.72
- VNDA $4.64
- Average True Range (ATR)
- HBB 0.54
- VNDA 0.15
- MACD
- HBB 0.10
- VNDA -0.01
- Stochastic Oscillator
- HBB 30.88
- VNDA 8.89
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.